Prognozy (mln) dla DongKook Pharmaceutical Co., Ltd.
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
| Przychód (średnia) |
805,500.00 |
906,750.00 |
1,006,200.00 |
1,112,500.00 |
1,210,800.00 |
| Przychód Δ r/r |
0.00% |
12.57% |
10.97% |
10.56% |
8.84% |
| Przychód (min) |
805,500.00 |
906,750.00 |
1,006,200.00 |
1,112,500.00 |
1,210,800.00 |
| Przychód (max) |
805,500.00 |
906,750.00 |
1,006,200.00 |
1,112,500.00 |
1,210,800.00 |
| EBITDA (średnia) |
114,148.66 |
128,496.95 |
142,590.17 |
157,654.10 |
171,584.35 |
| EBIT (średnia) |
90,129.72 |
101,458.87 |
112,586.62 |
124,480.83 |
135,479.90 |
| EBIT % |
11.19% |
11.19% |
11.19% |
11.19% |
11.19% |
| Zysk netto (średni) |
68,291.31 |
68,828.16 |
77,372.96 |
86,834.87 |
0.00 |
| Zysk netto % |
8.48% |
7.59% |
7.69% |
7.81% |
0.00% |
| EPS (średnia) |
1526.50 |
1538.50 |
1729.50 |
1941.00 |
0.00 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
0 |
| symbol |
086450.KQ |
086450.KQ |
086450.KQ |
086450.KQ |
086450.KQ |